Immune Checkpoint Inhibitors, Atherosclerotic Cardiovascular Events, and Plaque Progression Among Women With Cancer
In female patients treated with ICIs, 5% developed an ASCVD, and a history of cardiovascular events was a risk factor. In an imaging study, plaque progressed in a short time frame after ICI therapy.
Authors
- Markella V. Zanni (ORCID: https://orcid.org/0000-0002-4711-3956)
- Ryan J. Sullivan (ORCID: https://orcid.org/0000-0001-5344-6645)
- Carlos A. Gongora (ORCID: https://orcid.org/0000-0002-0383-2086)
- Hajnalka Vágó (ORCID: https://orcid.org/0000-0002-3568-3572)
- Hannah Gilman
- Júlia Karády (ORCID: https://orcid.org/0000-0002-6640-6260)
- Kerry L. Reynolds (ORCID: https://orcid.org/0000-0002-7793-654X)
- Jana Taron (ORCID: https://orcid.org/0000-0002-1388-7531)
- Borek Foldyna (ORCID: https://orcid.org/0000-0002-2466-4827)
- Giselle Alexandra Suero‐Abreu (ORCID: https://orcid.org/0000-0002-4274-2761)
- Zsófia D. Drobni (ORCID: https://orcid.org/0000-0002-1355-5318)
- Zoltán V. Varga (ORCID: https://orcid.org/0000-0002-2758-0784)
- Daniel A. Zlotoff (ORCID: https://orcid.org/0000-0001-9007-7295)
- Béla Péter Merkely (ORCID: https://orcid.org/0000-0001-6514-0723)
- Tomas G. Neilan (ORCID: https://orcid.org/0000-0002-1513-8833)
Institutions
- Semmelweis University (HU)
- Harvard University (US)
- University of Freiburg (DE)
- University Medical Center Freiburg (DE)
- Gordon Center for Medical Imaging (US)
- Massachusetts General Hospital (US)
Publication Details
- Journal
- Journal of the American Heart Association
- Published
- 2025-11-26
- DOI
- https://doi.org/10.1161/jaha.125.041925
- Citations
- 1
- Primary Topic
- Chemotherapy-induced cardiotoxicity and mitigation
- Type
- article
- Field-Weighted Citation Impact
- 1.39